Tanezumab in Osteoarthritis Of The Hip

Completed · Phase 3 · Has a placebo group

Conditions studied: Arthritis, Osteoarthritis, Osteoarthritis, Hip

In brief

The purpose of this study is to test the efficacy and safety of 3 doses of tanezumab in osteoarthritis of the hip in patients

Key facts

Study ID
NCT00744471
Run by
Pfizer
People needed
627
Starts
2008-11-17
Expected to finish
2010-08-13
Last updated by the study team
2021-02-26

Who can join

Age: 18 and older, up to 99. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.